Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis

Journal of Nuclear Medicine

Volumn 47, Issue 8, 2006, Pages 1281-1287

  Lebtahi, Rachida ^a,b,c   Moreau, Severine ^a   Marchand Adam, Sylvain ^a,b   Debray, Marie Pierre ^a   Brauner, Michel ^d   Soler, Paul ^b   Marchal, Joëlle ^b   Raguin, Olivier ^c   Gruaz Guyon, Anne ^c   Reubi, Jean Claude ^e   Le Guludec, Dominique ^a,b,c   Crestani, Bruno ^a,b  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d AVICENNE HOSPITAL   (France)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Fibroblasts; Pulmonary fibrosis; Somatostatin receptors

Indexed keywords

AZATHIOPRINE; CARBON MONOXIDE; PENTETREOTIDE IN 111; PREDNISONE; SOMATOSTATIN I 125; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; INDIUM; OCTREOTIDE;

ADULT; AGED; ARTICLE; ASSAY; AUTORADIOGRAPHY; BINDING ASSAY; BINDING SITE; CELL COUNT; CELL CULTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; FEMALE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LUNG; LUNG ALVEOLITIS; LUNG DIFFUSION CAPACITY; LUNG FIBROBLAST; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG PARENCHYMA; LUNG VOLUME; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC SCLEROSIS; TOTAL LUNG CAPACITY; VASCULARIZATION; VITAL CAPACITY; CLINICAL TRIAL; DRUG EFFECT; FIBROBLAST; LUNG FIBROSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; INDIUM RADIOISOTOPES; LUNG; MALE; MIDDLE AGED; OCTREOTIDE; PULMONARY FIBROSIS; RECEPTORS, SOMATOSTATIN;

EID: 33749048089     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment - international consensus statement. Am J Respir Crit Care Med. 2000;161:646-664.
2. Collard HR, Ryu JH, Douglas WW, et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest. 2004;125:2169-2174.
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136-151.
4. Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, openlabel phase II study. Am J Respir Crit Care Med. 1999;159:1061-1069.
5. Park SH, Saleh D, Giaid A, Michel RP. Increased endothelin-1 in bleomycin induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med. 1997;156:600-608.
6. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171:1040-1047.
7. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20:157-198.
8. Buscail L, Esteve J, Saint-Laurent N, et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci U S A. 1995;92:1580-1584.
9. Benali N, Cordelier P, Calise D, et al. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A. 2000;97:9180-9185.
10. Priestley GC, Aldridge RD, Sime PJ, Wilson D. Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro. Br J Dermatol. 1994;131:52-56.
11. Pasquali D, Vassallo P, Esposito D, Bonavolonta G, Bellastella A, Sinisi AA. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol. 2000;25:63-71.
12. Tracy TF Jr, Tector AJ, Goerke ME, Kitchen S. Lagunoff D. Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. Am J Pathol. 1993;143:1574-1578.
13. Fort J, Oberti F, Pilette C, et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology. 1998;28:1525-1531.
14. Turkcapar N, Bayar S, Koyuncu A, Ceyhan K. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice. Hepatogastroenterology. 2003;50:680-683.
15. Wang J, Zheng H, Sung CC, Hauer-Jensen M. The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int J Radiat Oncol Biol Phys. 1999;45:1289-1296.
16. Wang J, Zheng H, Hauer-Jensen M. Influence of short-term octreotide administration on chronic tissue injury, transforming growth factor beta (TGFbeta) overexpression, and collagen accumulation in irradiated rat intestine. J Pharmacol Exp Ther. 2001;297:35-42.
17. Mansy SS, Yehia HA, Hassan MM, et al. Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis. J Egypt Soc Parasitol. 1998;28:23-44.
18. Gunal AI, Duman S, Sen S, et al. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol. 2001;14:184-189.
19. Gugger M, Waser B, Kappeler A, Schonbrunn A, Reubi JC. Immunohistochemical localization of somatostatin receptor sst2Ain human gut and lung tissue: possible implications for physiology and carcinogenesis. Ann NY Acad Sci. 2004;1014:132-136.
20. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR. 1997;169:977-983.
21. Lebtahi R, Crestani B, Belmatoug N, et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med. 2001;42:21-26.
22. Weinmann P, Crestani B, Tazi A, et al. 111In-Pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. J Nucl Med. 2000;41:1808-1812.
23. Vanhagen PM, Krenning EP, Reubi JC, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med. 1994;21:497-502.
24. 111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs. J Nucl Med. 2003;44:1315-1321.
25. Reubi JC, Waser B, Sheppard M, Macaulay V. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer. 1990;45:269-274.
26. Lonneux M, Jamar F, Leners N, Pieters T, Pauwels S. Uptake of In-111 pentetreotide by pleural plaques. Clin Nucl Med. 1998;23:298-301.
27. Stoffel M, Jamar F, Donckier J, et al. Increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases. Eur J Nucl Med. 1996;23:723-726.
28. Kwekkeboom DJ, Krenning EP, Kho GS, Breeman WA, Van Hagen PM. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med. 1998;25:1284-1292.
29. Reubi JC, Waser B, Markusse HM, Krenning EP, VanHagen M, Laissue JA. Vascular somatostatin receptors in synovium from patients with rheumatoid arthritis. Eur J Pharmacol. 1994;271:371-378.
30. Vanhagen PM, Markusse HM, Lamberts SW, Kwekkeboom DJ, Reubi JC, Krenning EP. Somatostatin receptor imaging: the presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum. 1994;37:1521-1527.
31. ten Bokum AM, Hofland LJ, de Jong G, et al. Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas. Eur J Clin Invest. 1999;29:630-636.
32. Renzoni EA, Walsh DA, Salmon M, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med. 2003;167:438-443.
33. Reubi JC, Mazzucchelli L, Laissue JA. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology. 1994;106:951-959.
34. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232:560-567.